Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|September 20, 2022
Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicinMaría Ángeles Meléndez-Carmona, Mikel Mancheño-Losa, Albert Ruiz-Sorribas, et al.
Paediatric Drugs|February 28, 2025
Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World UseAlmudena Castro-Frontiñán, Luis Manuel Prieto-Tato, Jose Manuel Caro-Teller, et al.
Frontiers in Microbiology|October 16, 2018
Molecular Epidemiology of Staphylococcus aureus Bacteremia: Association of Molecular Factors With the Source of InfectionDafne Pérez-Montarelo, Esther Viedma, Nieves Larrosa, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised PatientsPilar Hernández-Jiménez, Francisco López-Medrano, Mario Fernández-Ruiz, et al.
IJID Regions|September 10, 2024
Simultaneous clonal spread of NDM-1-producing Pseudomonas aeruginosa ST773 from Ukrainian patients in the Netherlands and SpainMarta Hernández-García, Manuel González de Aledo, Manuel Ponce-Alonso, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 12, 2019
Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clonesRaúl Recio, Irina Sánchez-Diener, Esther Viedma, et al.
Journal of Global Antimicrobial Resistance|March 27, 2022
Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatmentPilar Hernández-Jiménez, Francisco López-Medrano, Mario Fernández-Ruiz, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 4, 2025
[Epidemiological characteristics of patients with carbapenemase-producing NDM Enterobacterales isolates in a high-complexity hospital]Cristina María Artiles-León, Sarita Rodríguez-Restrepo, Ivonne Andrea Torres-Jiménez, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence TypesJavier E Cañada-García, Eva Ramírez de Arellano, Miguel Jiménez-Orellana, et al.
Pageof 5